Form 4 for LH Labcorp
Accepted 2023-02-09 00:00:00 ET · period of report 2023-02-07 · accession 0001127602-23-004096 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-09 | 2023-02-07 | LH | Schroeder Mark S | EVP, Pres-Diagnostics Lab | S - Sale | $243.01 | -409 | 6,687 | -6% | -$99.4K |
| DM | 2023-02-09 | 2023-02-07 | LH | Schroeder Mark S | EVP, Pres-Diagnostics Lab | A - Grant | $0.00 | +5,790 | 4,400 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-07 | S | D | 409 | $243.01 | 6,687.40 | D | — | — | |
| 2 | Derivative | Restricted Stock Unit | 2023-02-07 | A | A | 1,390 | $0.00 | 3,104 | D | — · — to — | 1,390 Common Stock | (F4) This number reflects the aggregate number of Restricted Stock Units held by the reporting person. (F2) Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. (F3) The Restricted Stock Units vest in three equal annual installments beginning on February 7, 2024. |
| 3 | Derivative | Non-qualified Stock Options | 2023-02-07 | A | A | 4,400 | $0.00 | 4,400 | D | $247.24 · 2024-02-07 to 2033-02-06 | 4,400 Common Stock | (F5) Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. (F6) The option vests in three equal annual installments beginning on the date reflected in this column. |